The stock price of Staar Surgical Co (NASDAQ: STAA) has surged by 0.46 when compared to previous closing price of 19.44, but the company has seen a 6.49% gain in its stock price over the last five trading sessions. seekingalpha.com reported 2025-05-07 that STAAR Surgical Company. (NASDAQ:STAA ) Q1 2025 Earnings Conference Call May 7, 2025 5:15 PM ET Company Participants Brian Moore – VP, Investor Relations and Corporate Development Stephen Farrell – Chair of the Board, President and CEO Warren Faust – President and COO Deborah Andrews – Interim CFO Conference Call Participants Tom Stephan – Stifel Anthony Petrone – Mizuho Ryan Zimmerman – BTIG Patrick Wood – Morgan Stanley Operator Greetings and welcome to the STAAR Surgical First Quarter 2025 Earnings Webcast.
Is It Worth Investing in Staar Surgical Co (NASDAQ: STAA) Right Now?
Company’s 36-month beta value is 0.66.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 10 as “hold,” and 1 as “sell.”
The public float for STAA is 49.16M, and currently, short sellers hold a 12.65% ratio of that floaft. The average trading volume of STAA on May 09, 2025 was 1.19M shares.
STAA’s Market Performance
STAA’s stock has seen a 6.49% increase for the week, with a 29.42% rise in the past month and a -14.45% fall in the past quarter. The volatility ratio for the week is 6.45%, and the volatility levels for the past 30 days are at 5.78% for Staar Surgical Co The simple moving average for the last 20 days is 9.99% for STAA stock, with a simple moving average of -25.17% for the last 200 days.
Analysts’ Opinion of STAA
Many brokerage firms have already submitted their reports for STAA stocks, with Wells Fargo repeating the rating for STAA by listing it as a “Equal Weight.” The predicted price for STAA in the upcoming period, according to Wells Fargo is $17 based on the research report published on April 21, 2025 of the current year 2025.
Mizuho gave a rating of “Neutral” to STAA, setting the target price at $17 in the report published on February 12th of the current year.
STAA Trading at 10.89% from the 50-Day Moving Average
After a stumble in the market that brought STAA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -60.83% of loss for the given period.
Volatility was left at 5.78%, however, over the last 30 days, the volatility rate increased by 6.45%, as shares surge +23.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +14.28% upper at present.
During the last 5 trading sessions, STAA rose by +6.49%, which changed the moving average for the period of 200-days by -54.46% in comparison to the 20-day moving average, which settled at $17.76. In addition, Staar Surgical Co saw -19.60% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at STAA starting from BROADWOOD PARTNERS, L.P., who purchase 178,127 shares at the price of $15.32 back on Apr 08 ’25. After this action, BROADWOOD PARTNERS, L.P. now owns 13,510,391 shares of Staar Surgical Co, valued at $2,729,095 using the latest closing price.
BROADWOOD PARTNERS, L.P., the 10% Owner of Staar Surgical Co, purchase 8,200 shares at $15.08 during a trade that took place back on Apr 09 ’25, which means that BROADWOOD PARTNERS, L.P. is holding 13,518,591 shares at $123,676 based on the most recent closing price.
Stock Fundamentals for STAA
Current profitability levels for the company are sitting at:
- -0.04 for the present operating margin
- 0.76 for the gross margin
The net margin for Staar Surgical Co stands at -0.06. The total capital return value is set at -0.03. Equity return is now at value -19.14, with -14.97 for asset returns.
Based on Staar Surgical Co (STAA), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at 0.41.
Currently, EBITDA for the company is -5.72 million with net debt to EBITDA at 12.94. When we switch over and look at the enterprise to sales, we see a ratio of 2.75. The receivables turnover for the company is 3.96for trailing twelve months and the total asset turnover is 0.62. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.78.
Conclusion
In a nutshell, Staar Surgical Co (STAA) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
